- Ophthalmology
- Reproductive/Sexual Health
- Pain Management
- CNS/Neurological
- Inflammation
- Metabolic Diseases
- Gastrointestinal
- Regenerative Medicine
- Gene/Cell Therapy
- Multiple Therapeutics
- Other
- Dermatology
- Oncology
- Immunology
- Platform for Therapeutics
- Respiratory
- Cardiovascular
- Orphan/Rare Diseases
- Infectious Diseases
9:30 AM
-
Royale15 mins- Gastrointestinal
Eupraxia Pharmaceuticals is a biotechnology company focused on precision delivery of drugs into disease tissues using its proprietary Diffusphere technology. With its lead program in Eosinophilic Esop ... -
Plymouth15 mins- Ophthalmology
Epion Therapeutics is developing a minimally -invasive treatment for ectatic corneal disease that can bring early intervention to millions of patients globally. Our EpiSmart approach is a transformat ...
9:45 AM
-
Plymouth15 mins- Ophthalmology
Ashvattha Therapeutics is advancing a new class of clinical-stage nanomedicine therapeutics that traverse tissue barriers to selectively target activated cells only in regions of inflammation. Our tar ... -
Royale15 mins- Gastrointestinal
Our mission is to restore voluntary bowel and bladder function to patients with neurological conditions such as spinal cord injury or have complications from other diseases such as diabetes, Parkinson ...
10:00 AM
-
Astor50 minsThis session will begin with an overview of the HSBC Innovation Banking annual report summarizing financing trends in 2024. First-financing dollars more than doubled in 2024 compared to 2023, with 14 ...
-
Plymouth15 mins- Gene/Cell Therapy
Carina Biotech is clinical stage, immuno-oncology company developing CAR-T and other adoptive cell therapies for the treatment of solid cancers. Its lead candidate, CNA3103, targets LGR5 a cancer stem ... -
Royale15 mins- Multiple Therapeutics
Sarcomatrix Therapeutics Corp is pioneering muscle health innovation with our proprietary matrix-based platform and a robust pipeline of transformative therapies. Positioned to redefine muscle care, w ...
.jpg)
10:15 AM
-
Plymouth15 mins- Immunology
GeoVax is developing novel vaccines for infectious diseases and therapies for solid tumor cancers. Its lead clinical program is a next-generation COVID-19 vaccine for which GeoVax was awarded a BARDA- ... -
Royale15 mins- Metabolic Diseases
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexi ...
10:30 AM
-
Plymouth15 mins- Regenerative Medicine
EVast Bio is a US-based clinical-stage biotech spinoff and Delaware C Corp pioneering the development of small Extracellular Vesicle (sEV) therapeutics. Our proprietary platform leverages these natura ... -
.png)
Royale15 mins- Multiple Therapeutics
At Pirouette, we believe that innovation drives progress. Our dedicated team of engineers and scientists are developing the latest technologies to offer cutting-edge treatments that enhance patient ca ...
10:45 AM
-
Plymouth15 mins- Reproductive/Sexual Health
Vaneltix Pharma, Inc. is a private clinical stage biotech focused on developing pharmaceutical products for the treatment of urologic conditions with high unmet need, with a focus on bladder condition ... -
Royale15 mins- Oncology
SirnaMed Therapeutics is a pioneering biotechnology company driven by the vision of inventing a future without cancer. We are developing a novel class of RNA interference (RNAi) therapeutics that leve ...
11:00 AM
-
Astor50 minsGLP-1 analogs have changed the game for many people living with obesity, but the medical community is looking for improvements in delivery, side effect profiles and more. This panel will examine how i ...
-
Plymouth15 mins- Reproductive/Sexual Health
Daré Bioscience is a biopharmaceutical company committed to advancing innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of d ... -
Royale15 mins- Oncology
MetasTx is working to block metastases of cancer cells from solid tumors including prostate, breast and skin by early detection and blockade of mesenchymal-to-epithelial transition (EMT). Creating nov ...
11:15 AM
-
Royale15 mins- Oncology
Medicovestor, Inc pioneers novel Antibody Drug Conjugate (ADC) platforms to bridge the therapeutic gaps of existing ADCs. It leverages the complementary expertise and extensive experience of each memb ... -
Plymouth15 mins- Platform for Therapeutics
Seek Labs is developing a programmable rapid response therapeutic platform for target ablation that leverages CRISPR technology. The platform seeks and destroys infectious pathogens and disease-drivin ...
11:30 AM
-
Plymouth15 mins- Platform for Therapeutics
Bound Therapeutics is a pioneering biotechnology company dedicated to the development of RNA-based therapies targeting rare and refractory diseases, with a primary focus on oncology. Our proprietary p ... -
Royale15 mins- Oncology
Cellinfinity is a Yale University spinoff, seed funded company (raised $16 mil, including $3mil from NIH) that has developed novel: 1) in vivo CAR-T vectors and 2) multi-gene edited CAR-Ts against sol ...
1:00 PM
-
Astor50 minsNauman Shah leads a global team charged with driving business development strategy and pursuing transformational acquisitions, licensing, and partnership opportunities to advance Johnson & Johnson’s m ...
1:15 PM
-
.jpg)
Plymouth15 mins- CNS/Neurological
Ananda Scientific, is a research driven Biotech Company developing prescription medicines for neuropsychiatric health. We have six well-controlled Phase II (double blind placebo controlled) clinical t ... -
Royale15 mins- Oncology
CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous ...
1:30 PM
-
Royale15 mins- Oncology
TrAMPoline Pharma was founded with a vision to support the next generation of cellular immunotherapies to treat solid tumors. We are developing vectors encoding proprietary co-receptor and signaling p ... -
Plymouth15 mins- CNS/Neurological
Sound Pharma is developing the first drugs to treat hearing loss and tinnitus affecting 50M Americans (the largest CNS/PNS disease). It has advanced its novel small molecule (SPI-1005) through 13 stud ...
1:45 PM
-
Royale15 mins- Oncology
Clinical stage Radiopharmaceutical company with therapeutic and imaging molecules. Currently in Phase 1 and Phase 2. -
Plymouth15 mins- CNS/Neurological
Tonix is a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates. Tonix’s lead program, TNX-102 SL, is a U.S. FDA Fast-Track designated product can ...
2:00 PM
-
Astor50 minsA recent McKinsey analysis shows that first-time launches are projected to outnumber those from established companies by nearly two to one. As companies seek to move from the clinic to market, underst ...
-
Plymouth15 mins- CNS/Neurological
PathMaker Neurosystems is a clinical-stage company developing a breakthrough, non-invasive approach to the treatment of ALS (amyotrophic lateral sclerosis), an incurable neurodegenerative disease that ... -
Royale15 mins- Oncology
Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for the treatment of advanced solid tumors and othe ...
.jpg)
.jpg)
2:15 PM
-
Royale15 mins- Oncology
Greenwich LifeSciences (Nasdaq: GLSI) is a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating the safety and efficacy of GP2, an immunot ... -
.png)
Plymouth15 mins- CNS/Neurological
KeifeRx (www.keiferx.com) is on a mission to improve the lives of dementia patients and their families by slowing down the onset of dementia by years compared to current treatment options.
2:30 PM
-
Royale15 mins- Oncology
Rakuten Medical, Inc. is a global biotechnology company founded in 2010, dedicated to developing and commercializing precision cell-targeting therapies through our proprietary Alluminox™ platform. All ... -
Plymouth15 mins- CNS/Neurological
Magdalena Biosciences, Inc. has a paradigm shifting drug development approach, 12-24 months from plant collection to clinical POC study initiation possible; de-risk early with higher probability for f ...
2:45 PM
-
Plymouth15 mins- CNS/Neurological
Newron (SIX: NWRN, XETRA: NP5) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The Company is head ... -
Royale15 mins- Oncology
ImmuneOnco is a HK-listed (HK.1541), clinical stage biotech company focused on discovering and developing immunotherapies to treat cancer and other diseases. The most advanced program is phase III tim ...
3:00 PM
-
Royale15 mins- Oncology
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. In August 2024, the FDA approved ... -
Astor50 mins2024 saw a modest uptick compared to the past few years in successful biotech IPOs. In this panel, executives who survived the IPO gauntlet will share the lessons learned during the IPO process and th ...
-
Plymouth15 mins- CNS/Neurological
ProMIS Neurosciences Inc. is a clinical stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative disea ...
3:15 PM
-
Plymouth15 mins- CNS/Neurological
NurrOn Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company (Boston, USA) dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nur ... -
Royale15 mins- Oncology
At Asta Bio, we are a targeted radiotherapy company harnessing the superior properties of alpha emitter 211-Astatine in combination with our proprietary multispecific Radiobodies™ that together delive ...
3:30 PM
-
.png)
Plymouth15 mins- CNS/Neurological
Bostal LLC is an enabling platform technology pharmaceutical company. Established in New Jersey in 2004, Bostal expanded its global footprint, Bostal Drug Delivery, in China in 2013. With its long-act ... -
Royale15 mins- Oncology
RNA Nanobiotics was established to advance the RNA nanoparticle technology developed by Dr. Peixuan Guo at Ohio State University into an innovative targeted delivery system able to improve the therape ...
3:45 PM
-
Plymouth15 mins- Multiple Therapeutics
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in ... -
Royale15 mins- Dermatology
Azitra is a clinical stage biotech company focused on developing innovative therapies for precision dermatology. The Company's lead product, ATR-12, is an engineered strain of S. epidermidis to treat ...
4:00 PM
-
Astor50 minsThe recent Nobel Prize recognition of AI’s ability to model molecular interactions signals the high expectations for improving drug discovery. However, leading companies are already applying AI tools ...
-
Plymouth15 mins- Multiple Therapeutics
Cellphire Therapeutics is a clinical stage Biotech believes no-one should die from controllable hemorrhage. We are revolutionizing bleeding treatment with platelet derived therapeutics. With a late st ... -
Royale30 mins- Dermatology
Alphyn is developing first-in-class therapeutics for severe and prevalent skin diseases using its unique multiple bioactive Zabalafin Multi-Target Therapeutic Drug Platform. Zabalafin Hydrogel, the co ...
4:15 PM
-
Royale15 mins- Other
Dimer Pharmaceuticals is transforming cancer and neurodegenerative disease treatment with its innovative “Oncodegenic Approach.” This strategy leverages an epidemiological connection between these con ... -
Plymouth15 mins- Multiple Therapeutics
supernova bio, a bio-venture specializing in R&D, has developed innovative theragnostic therapies by creating gas-generating polymer nanoparticles that overcome the limitations of conventional chemoth ...
.jpg)
4:30 PM
-
Royale15 mins- Cardiovascular
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) is a biopharmaceutical company in advanced clinical development focused on developing tecarfarin, a novel oral and reversible anticoagulant for the preventio ... -
Plymouth15 mins- Gene/Cell Therapy
Nanoscope Therapeutics is developing gene-agnostic, sight-restoring optogenetic therapies for the millions of patients blinded by retinal degenerative diseases, for which no cure currently exists. Fol ...
9:00 AM
-
Astor50 minsWith the election of a new Congress, President, and agency leadership, there are questions about the trajectory of policies and guidelines and what will change for the biotech industry. As new priorit ...
9:15 AM
-
Plymouth15 mins- Oncology
Angiex makes vascular-targeted antibody-drug conjugates for the treatment of solid cancers. Angiex's lead drug, AGX101, a TM4SF1-directed microtubule inhibitor conjugate, is currently in Phase 1 trial ...
9:30 AM
-
Royale15 mins- Inflammation
Armed with a novel approach for resolving inflammation and expertise ranging from drug discovery through FDA approval, we merge future-focused intention with data-driven innovation. We have earned our ... -
Plymouth15 mins- Oncology
Leukogene is oncology focused company with mission to deliver innovative therapies with emphasis on immunologically “cold” tumors. Leukogene's proprietary MHCII targeted immunotherapy platform (M2T™) ...
9:45 AM
-
Royale15 mins- Pain Management
Sustained Therapeutics is a clinical stage company developing non-opioid locally injected therapeutics for the treatment of pain. Our novel sustained-release drug delivery platform has the potential t ... -
Plymouth15 mins- Oncology
Multimeric Biotherapeutics, Inc., is a preclinical company that is developing its patented FortiVac vaccine platform technology. FortiVac uses CD40 ligand (CD40L) as a natural adjuvant to activate den ...
10:00 AM
-
Astor50 minsOncology remains one of the top therapeutic areas garnering investor interest, and scientific advances are yielding new approaches that are showing sometimes game-changing clinical promise in treating ...
-
.jpg)
Royale15 mins- Orphan/Rare Diseases
Artasome Therapeutics is a pre-clinical stage company focused on the treatment of innate driven, inflammatory-fibrotic (IDIF) rare diseases associated with significant morbidity and mortality. NLRP3 a ... -
Plymouth15 mins- Oncology
Processa Pharmaceuticals develops products that improve survival and quality of life for patients with unmet medical needs. Using our years of regulatory experience, we identify de-risked, underapprec ...
.jpg)
10:15 AM
-
Royale15 mins- Orphan/Rare Diseases
Protalix is a biopharmaceutical company focused on the development, production, and commercialization of innovative medicines for patients living with rare diseases. We are advancing promising candida ... -
Plymouth15 mins- Oncology
VSPharmTech (VSPT), a clinical stage biotechnology company, has been dedicated to developing innovative therapeutics to achieve paradigm shift for cancer patients since its establishment in 2018. VSPT ...
10:30 AM
-
Royale15 mins- Orphan/Rare Diseases
BOOST Pharma is a clinical-stage biopharmaceutical company focused on the development of novel cell therapy treatments. The company is currently developing a first-in-class therapy to treat Osteogenes ... -
Plymouth15 mins- CNS/Neurological
Klotho Neurosciences, Inc. (NASDAQ: KLTO), is a biopharmaceutical company focused on the development of innovative, disease-modifying cell and gene therapies using a protein derived from a patented fo ...
10:45 AM
-
Royale15 mins- Orphan/Rare Diseases
EveryONE Medicines is committed to developing individualized anti-sense oligonucleotides targeting unique genetic variants causing severe neurodegenerative disease, even if unique to just one person. -
.png)
Plymouth15 mins- Regenerative Medicine
Xylyx Bio is a regenerative medicine company developing a platform of bioengineered human organs aimed at increasing the supply of organs for life-saving transplantation. The company's lead product is ...
11:00 AM
-
Astor50 minsAs venture capital remains difficult to reach, the availability of debt financing, royalty financing, family office funding, and other alternative methods, as well as PIPEs for public companies, becom ...
-
Royale15 mins- Immunology
Canopy is an emerging biotech redefining autoimmune therapeutics through its groundbreaking Antigen-Drug Conjugate (AgDC) platform. Backed by leading US-based VCs, the company is led by Dr. Kfir Oved, ... -
Plymouth15 mins- Respiratory
Inhalon Biopharma is a clinical-stage biotechnology company with a precedent-setting pulmonary drug delivery platform to treat patients suffering from acute respiratory infections such as RSV, influen ...
.jpg)
11:15 AM
-
Royale15 mins- Infectious Diseases
Ziphius is a biotechnology company developing best-in-class vaccines and therapeutics based on its proprietary saRNA and carrier technology (LNP) platform. This platform enables higher and prolonged p ... -
Plymouth15 mins- Regenerative Medicine
Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived ma ...
11:30 AM
-
Plymouth15 mins- Other
Akebia Therapeutics works to develop unique therapeutics that have the potential to set new standards of care for people living with kidney disease. Akebia is a fully integrated biopharmaceutical comp ... -
Royale15 mins- Dermatology
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our Specialized BioTherapeutics busi ...
1:00 PM
-
Astor50 minsThe October 2024 approval of the first schizophrenia drug with a new mechanism of action since the 1950s heralds an acceleration of investment interest in supporting new medicines for neuropsychiatric ...
.jpg)
1:15 PM
-
Royale15 mins- Gene/Cell Therapy
Medera (www.medera.bio) is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat or currently incurable diseases with next-generation gene and cell-based approaches. Meder ... -
.png)
Plymouth15 mins- CNS/Neurological
Gain Therapeutics, Inc. is a clinical-stage biotechnology company leading the discovery and development of next generation allosteric therapies. Gain’s lead drug candidate, GT-02287 is currently being ...
1:30 PM
-
.png)
Royale15 mins- Inflammation
Enveda is a biotechnology company aiming to understand and utilize the chemistry that forms the foundation of life. Using their AI-powered tools to identify and characterize the diverse molecules that ... -
Plymouth15 mins- CNS/Neurological
Developing AMPAkines for spinal injury, ADHD and Central Apnea (Phase 2). Developing GABAkines for treatment resistant epilepsy and non-opioid pain management (preclinical).
1:45 PM
-
Royale15 mins- Oncology
Pilatus Biosciences, a preclinical-stage biopharmaceutical company spun out from the Ludwig Institute for Cancer Research (Lausanne) in November 2022, stands on the cutting-edge of developing First-in ... -
Plymouth15 mins- Multiple Therapeutics
Johnson & Johnson’s external scientific innovation group works across the pharmaceutical and medical technology sectors to accelerate early-stage, transformational solutions by catalyzing the best ide ...
2:00 PM
-
Astor50 minsJohn Maraganore is a co-founder and executive chair of City Therapeutics. He was the founding CEO and a director of Alnylam Pharmaceuticals - the leading RNAi therapeutics company - which he led for n ...
-
Plymouth15 mins- Metabolic Diseases
CuriRx/CuriOralRx is a pioneering biotech company transforming the global landscape of peptide and protein therapeutics. With a specialized focus on developing advanced oral delivery systems for biolo ...
2:15 PM
-
Plymouth15 mins- Metabolic Diseases
Regor Therapeutics Group is a clinical-stage biotechnology company, headquartered in Cambridge, MA and with operations in Houston, San Diego, and Shanghai, which is developing innovative and clinicall ...
2:30 PM
-
Plymouth15 mins- Orphan/Rare Diseases
Lipella Pharmaceuticals is a clinical-stage biotechnology company focused on developing and commercializing innovative treatments for serious diseases. Our proprietary drug delivery technology offers ...
3:00 PM
-
Astor50 minsDespite an extended period of lower biopharma stock valuations and a start of declining interest rates, M&A totals remain historically low. With a new U.S. government administration taking office, and ...
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}